Antimalarial qinghaosu/artemisinin: The therapy worthy of a Nobel Prize
Malaria is a major cause of human morbidity and mortality in the tropical endemic countries worldwide. This is largely due to the emergence and spread of resistance to most antimalarial drugs currently available. Based on the World Health Organization recommendation, artemisinin-based combination th...
Main Authors: | Jerapan Krungkrai, Sudaratana Rochanakij Krungkrai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-05-01
|
Series: | Asian Pacific Journal of Tropical Biomedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2221169116302465 |
Similar Items
-
Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives
by: LUIZ C.S. PINHEIRO, et al. -
Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
by: Qi Jin, et al.
Published: (2023-02-01) -
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
by: Florian Kurth, et al.
Published: (2016-08-01) -
Genomic epidemiology of artemisinin resistant malaria
by: MalariaGEN Plasmodium falciparum Community Project
Published: (2016-03-01) -
Widespread Availability of Artemisinin Monotherapy in the United States
by: Robert M. Rakita, et al.
Published: (2011-05-01)